| |
| |
|
| Insider
Information: |
Mutz Christopher |
| Relationship: |
HEAD OF RARE DISEASE |
| City: |
Baudette |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
85,277 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,722,939 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
85,277 |
|
|
| Total
Value |
$5,722,939 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ANI Pharmaceuticals Inc |
ANIP |
HEAD OF RARE DISEASE |
2024-03-07 |
85,277 |
2021-02-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2024-03-07 |
4 |
D |
$66.71 |
$140,758 |
D/D |
(2,110) |
85,277 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2024-03-05 |
4 |
S |
$66.00 |
$330,000 |
D/D |
(5,000) |
87,387 |
0 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2024-02-29 |
4 |
D |
$67.67 |
$86,279 |
D/D |
(1,275) |
92,387 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2024-02-15 |
4 |
D |
$57.55 |
$72,571 |
D/D |
(1,261) |
93,662 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
31,316 |
94,923 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2023-11-10 |
4 |
S |
$52.47 |
$157,410 |
D/D |
(3,000) |
63,607 |
0 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2023-03-07 |
4 |
D |
$44.23 |
$84,125 |
D/D |
(1,902) |
37,660 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2023-02-15 |
4 |
D |
$45.04 |
$58,192 |
D/D |
(1,292) |
39,562 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2022-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,476 |
40,854 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2022-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
19,428 |
34,378 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
HEAD OF RARE DISEASE |
• – – |
2022-02-15 |
4 |
D |
$40.25 |
$47,656 |
D/D |
(1,184) |
14,950 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
CHIEF COMMERCIAL OFFICER |
• – – |
2021-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,134 |
16,134 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
